Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.
Gordon Cummins
Advertisement
Articles by Gordon Cummins
Advertisement
Latest Updated Articles
Refining, Rethinking, and Decentralizing Clinical ResearchPublished: February 26th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
2
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
3
Burnout and Shortages Put the Blood Supply at Risk
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5